Hany Massarany, a renowned leader in the global diagnostics industry, is joining the Planet Innovation Board as a non-executive director.
Hany brings more than 25 years of healthcare, life sciences and diagnostics experience, most recently as President and Chief Executive Officer of GenMark Diagnostics (NASDAQ: GNMK) from 2011 to 2020.
Prior to joining GenMark, Hany was at Ventana Medical Systems (a member of the Roche Group) from 1999 to 2009, where he held various global leadership positions, including President of Ventana Medical Systems and Head of Roche Tissue Diagnostics.
Hany has also held executive management positions with Bayer Diagnostics and Chiron Diagnostics, working in Asia Pacific and the United States.
Hany said: “I’m delighted to join PI and look forward to working with the team to accomplish our company objectives.
“Continuing to accelerate the profitable growth of our core design and manufacturing services is a critical business priority, both in Australia and other global markets. I’m also excited about the significant potential provided by several of our new businesses.”
Planet Innovation co-founder and co-CEO Stuart Elliott added: “Hany brings a wealth of experience in the U.S. and global diagnostics markets, which are a key area of growth for PI. His input will be invaluable as we continue to expand our Services offering and also grow our spin-off businesses, particularly Lumos Diagnostics.
“With Hany’s appointment, and the addition of Jonathan Ling and Jim Fox earlier this year, we now have three successful CEOs on the board. Sam and I are delighted to have access to this level of experience and expertise to guide our business during the next phase of growth.”
